WHEELING, Ill., Jan. 7, 2022 /PRNewswire/ — It is with profound senses of loss and sadness that SG 360° announces the sudden and unexpected death of their President and CEO John A. Wallace, Jr., who Read more…
UK Construction PMI cools off The UK Construction PMI for December indicated that growth at cooled off and fallen to a 3-month low. The PMI slowed to 54.3, down from 55.5 in November. Although the Read more…
PARIS, Ky., Jan. 7, 2022 /PRNewswire/ — A&G Real Estate Partners and Murray Wise Associates LLC are under contract with a stalking horse bidder in the receivership sale of a 1.87 million-square-foot greenhouse and agricultural Read more…
LONDON, Jan. 7, 2022 /PRNewswire/ — Highgate, the fast-growing global CEO and sovereign advisory firm, has kick-started 2022 with two new senior level appointments. APCO UK’s Deputy Managing Director Polly Kennedy joins Highgate as Chief Operating Read more…
LOS ANGELES, Jan. 7, 2022 /PRNewswire/ — Homestead Entertainment unveils new movies the first week of January on Tubi, a Fox Entertainment Company. Beginning Friday, January 7, 2022, new film releases and tv shows broadcast with relevant Read more…
VIRGINIA BEACH, Va., Jan. 07, 2022 (GLOBE NEWSWIRE) — Armada Hoffler Properties, Inc. (AHH) – Get Armada Hoffler Properties, Inc. Report today announced that it has priced an underwritten public offering of 3,500,000 shares of Read more…
DUBLIN, Jan. 7, 2022 /PRNewswire/ — The “Automatic Power Factor Controller Market Research Report by Type, Component, Installation Type, Industry, and Region – Global Forecast to 2026 – Cumulative Impact of COVID-19” report has been Read more…
CHICAGO, Jan. 7, 2022 /PRNewswire/ — According to the report “ Polyolefin Pipes Market by Type (PE, PP, Plastomer), Application (Irrigation, Potable & Plumbing, Wastewater Drainage, Power & Communication, Industrial), End-use Industry (Building & Construction, Read more…
RED BANK, N.J., Jan. 7, 2022 /PRNewswire/ — Provention Bio, Inc. (Nasdaq: PRVB) (the “Company”), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the Company granted stock options to Randy Read more…
Royalty Pharma Extends Capital to Cytokinetics to Support the Commercial Launch of Omecamtiv Mecarbil and the Further Development of Aficamten Royalty Pharma Purchases Royalties on Future Sales of Aficamten Cytokinetics to Host Conference Call and Read more…